IBTC
Monochrome Bitcoin ETF
π¦πΊ ASX
π Overview
π Performance
π Holdings
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
N/A
Annual Growth
5 years average annual growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
9
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Monochrome Bitcoin ETF
π Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ Top Holdings
Show moreTop holdings information is not yet available for this fund. For more information please visit the fund manager's website.
π΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$10.30
π° Price To Earnings Ratio
0.00
π° Price To Book Ratio
0.00
π° Leveraged
No
π° Inverse
No
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in IBTC
9
π Total Capital Earnings
$9K
π Average investment frequency
13 weeks
π΅ Average investment amount
$2,083
β° Last time a customer invested in IBTC
1 hours
IBTC investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
25%
Less than 50k
67%
πΆ Age of investors
18 - 25
11%
26 - 34
33%
35 - 90
56%
π Legal gender of investors
Female
44%
Male
56%
Pearlers who invest in IBTC also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
3.85%
π Share price
$100.90 AUD
β³οΈ DIVERSIFIED
π¦πΊ AUSTRALIA
𧱠MATERIALS
πΈ FINANCIALS
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 6138.42m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
π Performance (5Yr p.a)
4.31%
π Share price
$135.91 AUD
β³οΈ DIVERSIFIED
πΈ FINANCIALS
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
π Performance (5Yr p.a)
24.88%
π Share price
$45.04 AUD
π€ TECHNOLOGY
π HIGH PRICE GROWTH
πΊπΈ UNITED STATES
ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.
π Performance (5Yr p.a)
13.00%
π Share price
$15.13 AUD
π¦πΊ EX AUSTRALIA
π HIGH PRICE GROWTH
β³οΈ DIVERSIFIED
π€ TECHNOLOGY
Want more shares? Try these...
IBUY.AX was created on 2022-02-14 by BetaShares. The fund's investment portfolio concentrates primarily on consumer discretionary equity. IBUY.AX aims to track the performance of an Index (before fees and expenses) that provides exposure to a portfolio of the worlds leading online retailers.
π Share price
$14.24 AUD
ποΈ CONSUMER
Imagion Biosystems Ltd. engages in the research and development of non-radioactive and safe diagnostic imaging technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-06-22. The firm uses bio-safe magnetic nanoparticles to detect cancer and other diseases. Its principal activity consists of nanotechnology, biotechnology, cancer diagnostics and medical imaging using magnetic resonance. The firm operates through Research and Development segment. The company is advancing clinical development of its MagSense platform technology to revolutionize cancer diagnosis, introducing molecular imaging to Magnetic resonance imaging (MRI). The Companyβs lead program has demonstrated its technology embodied in MagSense HER2 Imaging Agent (MSH2IA) is safe and well-tolerated in patients diagnosed with HER2+ breast cancer. Its MagSense pipeline includes prostate cancer, ovarian cancer, pancreatic cancer, and brain cancer programs. Its PrecisionMRX products include Dextran-Coated, mPEG Coated, Oleic Acid Coated and Carboxylic Acid Functionalized.
π Performance (5Yr p.a)
30.48%
π Share price
$0.05 AUD
π HIGH PRICE GROWTH
π©Ί HEALTH CARE